Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tumor Lysate Pulsed-Dendritic Cell Vaccines for NHL
NCT00006434Phase 3Completed
- Sponsor
- National Center for Research Resources
- Modality
- Whole Cell Cancer Vaccines, Dendritic Cell Vaccines
- Countries
- 1
01
Overview
Phase 3 trial of tumor-pulsed dendritic cells in non-Hodgkin lymphoma (NHL), sponsored by National Center for Research Resources. Primary endpoints: Safety and side effects and Response of the immune system. Status: completed.
02
Drugs
tumor-pulsed dendritic cells
03
Conditions
non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT00006434.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00006434.